refresh

トレンド企業

Trending

採用

Jobs

Intellia

Intellia

Intellia

Focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.

Gene Editing

CRISPR Technology

Cell Engineering

Bioinformatics

Drug Development

Cambridge, MA

201-500

Founded 2014 (12yrs)

Hybrid

Public

Valuation

$1.2B

Total Funding

$70M

Last Round

Series B

NTLA

$11.87

Revenue (2026)

$0

Operating Income

$0

Open Positions

0 positions

No open positions at this time

Products & Services

NT

NTLA-2001

Gene Editing Therapy

NT

NTLA-2002

Gene Editing Therapy

NT

NTLA-5001

Cell Therapy

NT

NTLA-3001

Gene Editing Therapy

AS

Asgard Platform

Platform Technology

EN

Engineered Cell Medicines

Cell Therapy

NT

NTLA-2003

Gene Editing Therapy

Total Views

0

Apply Clicks

0

Mock Applicants

0

Scraps

0

Reviews

3.7

1 reviews

Work Life Balance

3.0

Compensation

2.5

Culture

1.5

Career

1.5

Management

1.0

15%

Recommend to a Friend

Cons

Poor management decision-making

Layoffs of long-tenured staff

Inconsistent treatment of employees

Salary Ranges

54 data points

Mid/L4

Mid/L4

1 reports

$214,500

total / year

Base

$165,000

Stock

-

$214,500

$214,500

Interview Experience

1 interviews

Difficulty

3.0

/ 5

Duration

2-5w

Interview Process

1

Application Review

2

HR Screen

3

Hiring Manager Interview

4

Panel Interview

5

Offer

Contact & Location